PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00004002 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Lymphoma
Small Intestine Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: bortezomib

Sponsor

NYU Langone Health

Collaborators

[object Object]